Evonik Study Points to Benefits of Anthocyanins For Cognitive Health

dd2430cb-0de9-48ca-8899-2d2cb9b3b903articleimage.jpg

08 May 2017 --- Anthocyanins may benefit cognitive health, according to studies conducted by Evonik and Professor Dag Aarsland, a specialist in dementia and dementia research at King’s College in London. Anthocyanins are naturally occurring antioxidants predominantly found in blue, purple, red or bluish-black fruits and vegetables. Evonik produces a proprietary anthocyanin-rich extract from wild Scandinavian bilberries and blackcurrants from New Zealand. The extract, marketed as an ingredient for functional foods under the name Healthberry, is also used in MEDOX, a highly successful nutritional supplement available in Norway.

Scientific studies suggest that anthocyanins have cardiovascular benefits. Recently, attention has turned to their potential advantages for cognitive health. A past study carried out by Professor Aarsland’s team demonstrated that the anthocyanins in MEDOX safeguard cells and cells transfected with Alzheimer mutation against neurotoxic substances. 

On that basis, a team of researchers at the Center for Age-Related Research at the Stavanger University Hospital decided to conduct a placebo-controlled clinical trial with elderly participants having an elevated risk of dementia. Specifically, they investigated whether the anthocyanins can prevent memory dysfunction. 

Dr. Anne Katrine Bergland, a specialist in geriatric medicine from Professor Aarsland’s team, and Dr. Ian Grayson from Evonik will report on these promising new findings on 9 May at Vitafoods. Moreover, Evonik will showcase ways to formulate Healthberry in functional foods, such as effervescent tablets, energy bars and gummy bears.

Evonik will also present its controlled release technologies for ingredients in nutritional supplements, which allow for a precise dosage and bioavailability improvement. 

Dr. Ludger Eilers, Director Food Segment at Evonik, explains: “Advanced formulations with controlled release characteristics are gaining importance. With our EUDRAGUARD functional excipient platform and extensive formulation technology experience, we can help customers develop the next generation of nutraceuticals and functional foods.” 

A global network of application technology laboratories enables Evonik to provide customers with local support for the development of innovative formulations – from feasibility studies to analytics, prototyping and commercial-scale manufacturing in a network of trusted partners.

RELATED ARTICLES
Homepicture

Roadmap: Researchers publish recommendations for successful EU health food claims

14 Nov 2017 Researchers have developed recommendations to ...

Homepicture

BASF plant fire: Force Majeure for vitamins and carotenoids at Citral plant

10 Nov 2017 BASF has announced that it has shut down its ...

Homepicture

Ajinomoto enters US medical foods market with Cambrooke Therapeutics acquisition

09 Nov 2017 Ajinomoto Co. Inc has acquired an equity ...

Homepicture

Frutarom fortifies portfolio with acquisition of AB-Fortis activity

08 Nov 2017 Frutarom has signed an agreement with AB-Biotics ...